Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PLA2G6 antibody

This Rabbit Polyclonal antibody specifically detects PLA2G6 in ELISA and IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7191907

Quick Overview for PLA2G6 antibody (ABIN7191907)

Target

See all PLA2G6 Antibodies
PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

Reactivity

  • 34
  • 31
  • 18
Human

Host

  • 49
  • 7
Rabbit

Clonality

  • 52
  • 4
Polyclonal

Conjugate

  • 32
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PLA2G6 antibody is un-conjugated

Application

  • 45
  • 14
  • 13
  • 13
  • 11
  • 10
  • 9
  • 8
  • 8
  • 5
  • 3
ELISA, Immunohistochemistry (IHC)
  • Cross-Reactivity

    Human, Mouse, Rat

    Purification

    Antigen affinity purification

    Immunogen

    Synthetic peptide of Human PLA2G6

    Isotype

    IgG
  • Application Notes

    ELISA:1:2000-1:5000, IHC:1:15-1:50,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    PLA2G6 (Phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6))

    Alternative Name

    PLA2G6

    Background

    Background: The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date.

    Aliases: 85 kDa calcium independent phospholipase A2 antibody, 85/88 kDa calcium-independent phospholipase A2 antibody, BB112799 antibody, CaI PLA2 antibody, CaI-PLA2 antibody, CaIPLA2 antibody, Calcium independent phospholipase A2 antibody, CTA-228A.2 antibody, Cytosolic calcium independent phospholipase A2 antibody, EC 3.1.1.4 antibody, Group VI phospholipase A2 antibody, Group VI, A antibody, GVI antibody, GVI PLA2 antibody, INAD1 antibody, Intracellular membrane associated calcium independent phospholipase A2 beta antibody, Intracellular membrane-associated calcium-independent phospholipase A2 beta antibody, iPLA(2)beta antibody, iPLA2 beta antibody, iPLA2-beta antibody, IPLA2-VIA antibody, iPLA2beta antibody, NBIA2 antibody, NBIA2A antibody, NBIA2B antibody, Neurodegeneration with brain iron accumulation 2 antibody, OTTHUMP00000199457 antibody, PARK14 antibody, Patatin like phospholipase domain containing 9 antibody, Patatin like phospholipase domain containing protein 9 antibody, Patatin-like phospholipase domain-containing protein 9 antibody, Phospholipase A2 calcium independent antibody, Phospholipase A2 calcium independent group VI A antibody, Phospholipase A2 group VI antibody, Phospholipase A2 group VI cytosolic calcium independent antibody, Phospholipase A2, group VI (cytosolic, calcium independent) antibody, PLA2 antibody, PLA2G6 antibody, PLPL9_HUMAN antibody, PNPLA9 antibody

    UniProt

    O60733

    Pathways

    Positive Regulation of Peptide Hormone Secretion
You are here:
Chat with us!